December 2 - 3, 2024
Workshop on In Silico Drug Design and Repurposing for Rare Diseases
Organized by the Arab-German Young Academy of Sciences and Humanities (AGYA) in cooperation with Institut Pasteur de Tunis
There are 7000 rare diseases affecting 300 millions people around the world. Among these diseases, only 5% have approved FDA drugs. The field of rare disease research faces unique challenges, especially in the discovery and repurposing of therapeutic drugs. In silico approaches, leveraging computational techniques and artificial intelligence, have opened new pathways to accelerate drug discovery processes. These innovative tools enable the identification of potential drug candidates and repurposing of existing therapies, providing hope for many affected by rare genetic disorders.
This workshop at the Institut Pasteur de Tunis will create a vital opportunity to collaborate and advance drug discovery efforts. Tailored for PhD students, researchers, clinicians, and pharmacists, industry professionals, and everyone passionate about revolutionizing the management of rare diseases, the workshop will leverage computational techniques and bioinformatics tools to identify new drug candidates and repurpose existing therapies for these kind of conditions.
Through interactive sessions and collaborative discussions, participants will explore innovative strategies, exchange knowledge, share best practices, and tackle key challenges in this rapidly evolving field. By strengthening expertise and fostering collaboration, the workshop aims to accelerate the development of effective therapies that address the unmet needs of individuals affected by rare diseases, improving both patient outcomes and quality of life.
Date: December 2-3, 2024
Time: 08:00 am - 05:00 pm
Venue: Institut Pasteur de Tunis, Tunisia
Language: English
Participation: Free
Deadline to Register: November 25, 2024
Join us in this unique journey as we push the boundaries of drug discovery for rare diseases! To Participate, kindly register here
The workshop offers limited spots:
- Practical Sessions: 15 participants
- Conference Sessions: 30 participants
This workshop focuses on exploring innovative computational techniques and artificial intelligence tools to accelerate drug discovery and repurpose existing therapies for rare diseases. It is an excellent opportunity for PhD students, researchers, clinicians, pharmacists, and industry professionals to collaborate and tackle challenges in rare disease research.
Over two days, participants will engage in interactive sessions to exchange knowledge, explore cutting-edge strategies, and share best practices to improve therapeutic development for rare genetic disorders.
About AGYA
The Arab-German Young Academy of Sciences and Humanities (AGYA) is based at the Berlin-
Brandenburg Academy of Sciences and Humanities (BBAW) and at the Academy of Scientific Research and Technology (ASRT) in Egypt. It was established in 2013 as the first bilateral young academy worldwide. AGYA promotes research cooperation among outstanding early-career researchers (3–10 years post-PhD) from all disciplines who are affiliated with a research institution in Germany or in any Arab country.
The academy effectively supports the interdisciplinary projects and collaborative initiatives of its members in various fields of scientific research, science policy and education. AGYA is funded by the German Federal Ministry of Education and Research (BMBF) and various Arab and German cooperation partners.
